Тёмный

Treatment and Management of Transthyretin-mediated (ATTR) Amyloidosis 

Heart Failure Society of America
Подписаться 3,2 тыс.
Просмотров 495
50% 1

The management of patients with transthyretin amyloidosis includes 2 main categories of disease-modifying therapies. This video discusses the role of TTR stabilizers and TTR silencers/knockdown agents along with heart failure and arrhythmia management for the management of patients with cardiac ATTR.
Please visit our post-module evaluation survey as well!
Link to survey: www.surveymonk...
Visit our website: hfsa.org/cardi...
HFSA LinkedIn: / hfsa
HFSA Twitter: / hfsa
HFSA Learning Center: learningcenter...

Опубликовано:

 

15 окт 2024

Поделиться:

Ссылка:

Скачать:

Готовим ссылку...

Добавить в:

Мой плейлист
Посмотреть позже
Комментарии    
Далее
Multidisciplinary Care of Amyloidosis
2:57
ATTR: What Treatments are in our Future
15:14
When Khabib dropped Conor McGregor 👀 #nocommentary
00:59
Transthyretin Amyloid and New Treatment Options
16:33
Просмотров 4,6 тыс.
Antibiotics "Pediatric Infectious Diseases I"
41:22
Просмотров 93 тыс.
ATTR Cardiac Amyloidosis: Treating the Symptoms
16:42
Просмотров 1,8 тыс.
Living with Transthyretin Amyloidosis (ATTR)
3:46
Просмотров 2,6 тыс.
Cardiac Amyloidosis: Update on Diagnosis and Treatment
48:45
When Khabib dropped Conor McGregor 👀 #nocommentary
00:59